Using a highly sensitive ELISA assay, we found that the serum concentration of autoantibody to HER2 (HER2‐AAb) in patients with early stage breast cancer is significantly lower (p = 1.8 × 10–7) than that in healthy subjects.11 Here, ERBB2 is linked to breast cancer.